secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001493152-24-004587
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma announces 1-for-30 reverse stock split to regain Nasdaq compliance
-------------------------------------------------------------------------------

- Reverse split ratio 1:30 effective 5:00 PM ET Feb 2, 2024; post-split trading begins Feb 5.
- Outstanding shares reduced from ~41.4M to ~1.38M; authorized shares unchanged at 250M.
- No fractional shares issued; stockholders receive cash for fractional shares.
- Proportionate adjustments to outstanding stock options and equity awards.
- Action intended to regain Nasdaq $1.00 minimum bid price; ticker remains GTBP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315224004587/0001493152-24-004587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315224004587/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer